Brian Concannon - 02 Feb 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
Sarah M. Oliker for Brian Concannon by Power of Attorney
Issuer symbol
CNMD
Transactions as of
02 Feb 2022
Net transactions value
-$1,277,275
Form type
4
Filing time
04 Feb 2022, 16:12:07 UTC
Previous filing
03 Jun 2021
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Sale $273,827 -2,027 -13% $135.09 13,400 02 Feb 2022 Direct F1
transaction CNMD Common Stock Sale $575,232 -4,200 -31% $136.96 9,200 02 Feb 2022 Direct F2
transaction CNMD Common Stock Sale $27,582 -200 -2.2% $137.91 9,000 02 Feb 2022 Direct F3
transaction CNMD Common Stock Options Exercise $175,957 +2,549 +28% $69.03 11,549 02 Feb 2022 Direct
transaction CNMD Common Stock Sale $344,319 -2,549 -22% $135.08 9,000 02 Feb 2022 Direct F4
transaction CNMD Common Stock Options Exercise $173,070 +2,165 +24% $79.94 11,165 02 Feb 2022 Direct
transaction CNMD Common Stock Sale $292,448 -2,165 -19% $135.08 9,000 02 Feb 2022 Direct F5
transaction CNMD Common Stock Options Exercise $136,271 +1,843 +20% $73.94 10,843 02 Feb 2022 Direct
transaction CNMD Common Stock Sale $248,916 -1,843 -17% $135.06 9,000 02 Feb 2022 Direct F6
transaction CNMD Common Stock Options Exercise $33,430 +1,000 +11% $33.43 10,000 02 Feb 2022 Direct
transaction CNMD Common Stock Tax liability $33,506 -241 -2.4% $139.03 9,759 02 Feb 2022 Direct
transaction CNMD Common Stock Options Exercise $39,640 +1,000 +10% $39.64 10,759 02 Feb 2022 Direct
transaction CNMD Common Stock Tax liability $39,763 -286 -2.7% $139.03 10,473 02 Feb 2022 Direct
transaction CNMD Common Stock Options Exercise $55,700 +1,000 +9.5% $55.70 11,473 02 Feb 2022 Direct
transaction CNMD Common Stock Tax liability $55,751 -401 -3.5% $139.03 11,072 02 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -2,549 -100% $0.000000* 0 02 Feb 2022 Common Stock 2,549 $69.03 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -2,165 -100% $0.000000* 0 02 Feb 2022 Common Stock 2,165 $79.94 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1,843 -100% $0.000000* 0 02 Feb 2022 Common Stock 1,843 $73.94 Direct F8
transaction CNMD Sars (Stock Appreciation Rights) Options Exercise $0 -1,000 -100% $0.000000* 0 02 Feb 2022 Common Stock 1,000 $33.43 Direct F9
transaction CNMD Sars (Stock Appreciation Rights) Options Exercise $0 -1,000 -100% $0.000000* 0 02 Feb 2022 Common Stock 1,000 $39.64 Direct F10
transaction CNMD Sars (Stock Appreciation Rights) Options Exercise $0 -1,000 -100% $0.000000* 0 02 Feb 2022 Common Stock 1,000 $55.70 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.29 to $137.06. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.88 to $137.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.84. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F7 The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
F8 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
F9 The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.
F10 The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.